Myriad faces yet another patent battle

28-11-2013

Myriad faces yet another patent battle

Genetic diagnostics company Invitae Corporation has requested declaratory judgment at the US District Court for the Northern District of California that it does not infringe 11 patents owned or exclusively licensed to Myriad Genetics.


Myriad Genetics, Invitae, patent infringement, declaratory judgment, gene testing

LSIPR